- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
BRG1 (SMARCA4) is an ATP-dependent chromatin remodeling enzyme that functions as the catalytic subunit of the SWI/SNF chromatin remodeling complex and regulates transcription by altering nucleosome positioning and chromatin accessibility. BRG1 Antibody / SMARCA4 (clone BRG1/7633R) recognizes the BRG1 protein encoded by the SMARCA4 gene and is produced as a recombinant rabbit monoclonal antibody designed to provide consistent detection of this chromatin remodeling ATPase. BRG1, also referred to as Brahma related gene 1, is a large nuclear protein that plays an essential role in transcriptional regulation, cellular differentiation, and tumor suppression pathways through its ability to regulate chromatin structure and gene expression programs.
BRG1 localizes primarily to the cell nucleus where it functions within the SWI/SNF chromatin remodeling complex to reposition nucleosomes and regulate access of transcription factors to regulatory DNA elements. Through ATP hydrolysis, BRG1 remodels chromatin architecture and enables activation or repression of gene expression programs involved in development, cell cycle progression, and cellular differentiation. Because of this central regulatory role in chromatin remodeling, SMARCA4 is widely studied in molecular biology and cancer research focused on transcriptional regulation and epigenetic control mechanisms.
Clone BRG1/7633R is developed as a recombinant rabbit monoclonal antibody, combining the high affinity binding characteristics typical of rabbit-derived antibodies with the consistency of recombinant antibody production. Recombinant rabbit monoclonal antibodies are generated from defined antibody sequences expressed in controlled recombinant systems, allowing reproducible antibody production and stable epitope recognition across manufacturing batches. This recombinant rabbit monoclonal antibody format supports reliable detection of BRG1 protein in studies investigating chromatin remodeling complexes and transcriptional regulatory pathways.
SMARCA4 plays an important tumor suppressor role and alterations in BRG1 expression have been reported in multiple malignancies. Loss or mutation of SMARCA4 has been identified in cancers including lung carcinoma, thoracic sarcoma, ovarian small cell carcinoma of hypercalcemic type, and other tumors associated with disruption of SWI/SNF chromatin remodeling components. Because of these biological roles, BRG1 detection is frequently used in research investigating chromatin remodeling defects and tumor-associated alterations in SWI/SNF complex function.
BRG1 Antibody / SMARCA4 (clone BRG1/7633R) therefore provides a recombinant rabbit monoclonal antibody reagent suitable for detecting the BRG1 chromatin remodeling ATPase in studies examining transcriptional regulation, chromatin remodeling biology, and SWI/SNF complex activity.
Optimal dilution of the BRG1 antibody should be determined by the researcher.
A recombinant partial protein sequence (within amino acids 200-400) from the human protein was used as the immunogen for the BRG1 antibody.
Aliquot the BRG1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
SMARCA4 antibody, BRG1 antibody, Brahma related gene 1 antibody, SWI/SNF chromatin remodeling ATPase antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.